Oliver Lagore Vanvalin Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$135K Buy
+432
New +$122K 0.05% 162
2024
Q4
$113K Hold
432
0.03% 168
2024
Q3
$139K Hold
432
0.04% 147
2024
Q2
$135K Sell
432
-54
-11% -$15.9K 0.04% 144
2024
Q1
$138K Buy
486
+4
+0.8% +$1.17K 0.04% 153
2023
Q4
$139K Buy
482
+39
+9% +$10.6K 0.05% 128
2023
Q3
$119K Buy
443
+111
+33% +$27.7K 0.05% 154
2023
Q2
$73.7K Hold
332
0.03% 207
2023
Q1
$80.3K Buy
332
+275
+482% +$67.5K 0.03% 151
2022
Q4
$15K Buy
57
+56
+5,600% +$15K 0.01% 312
2022
Q3
$0 Hold
1
﹤0.01% 628
2022
Q2
$0 Buy
+1
New +$245 ﹤0.01% 610

Other funds holding AMGN

Oliver Lagore Vanvalin Investment Group's AMGN Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Amgen (AMGN) in Q2 2025: 432 shares worth $135K. The stake represents 0.05% of the portfolio and ranks #162 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in AMGN as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in AMGN in Q2 2022 and has held it in 12 quarters since. The position peaked at $139K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 432 shares of Amgen worth $135K as of Q2 2025.
  • Amgen was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Amgen made up 0.05% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #162 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Amgen in Q2 2022 and has held it in 12 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Amgen position peaked at $139K in Q3 2024.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.